Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol. 2015;21(1):60-70.   Published online 2015 Mar 25     DOI: https://doi.org/10.3350/cmh.2015.21.1.60
Citations to this article as recorded by Crossref logo
Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
Matthias Ocker
World Journal of Gastroenterology.2020; 26(3): 279.     CrossRef
Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma
Yuri Cho, Min Ji Park, Koeun Kim, Jae-Young Park, Jihye Kim, Wonjin Kim, Jung-Hwan Yoon
International Journal of Molecular Sciences.2020; 21(2): 472.     CrossRef
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Sung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, Aleksei Babich, Rong Liu, Takahiko Tanigawa, Anette Sommer, Motonobu Osada, Frank Reetz, Dirk Laurent, Sabine Wittemer-Rump, Jordan Berlin
Targeted Oncology.2019; 14(5): 591.     CrossRef
The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma
Prachi Rana, John Haydek, Anjana Pillai
Current Hepatology Reports.2019; 18(4): 371.     CrossRef
Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma
Oleg V. Grinchuk, Surya P. Yenamandra, Ramakrishnan Iyer, Malay Singh, Hwee Kuan Lee, Kiat Hon Lim, Pierce Kah-Hoe Chow, Vladamir A. Kuznetsov
Molecular Oncology.2018; 12(1): 89.     CrossRef
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, Richard S. Finn
Nature Reviews Clinical Oncology.2018; 15(10): 599.     CrossRef
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib
Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Min Jung Oh, Dae Ryong Kang, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Min Jae Yang, Jae Chul Hwang, Sun Gyo Lim, Sung Jae Shin, Kee Myung Lee, Byung Moo Yoo, Kwang Jae Lee, Sung Won Cho, Jae Youn Cheong
Cytokine.2017; 95: 118.     CrossRef
Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis
Gang Liu, Disheng Xiong, Rui Xiao, Zhengjie Huang
Tumor Biology.2017; 39(6): 101042831770742.     CrossRef
Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma
Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Jung-Hwan Yoon
Digestive Diseases and Sciences.2016; 61(9): 2568.     CrossRef
125I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma
Peng-Hui Hu, Lan-Hong Pan, Patrick Ting-Yat Wong, Wen-Hui Chen, Yan-Qing Yang, Hong Wang, Jun-Jian Xiang, Meng Xu
World Journal of Gastroenterology.2016; 22(21): 5033.     CrossRef
NGS-based identification of druggable alterations and signaling pathways – hepatocellular carcinoma case report
E. A. Kotelnikova, M. D. Logacheva, E. R. Nabieva, M. A. Pyatnitskiy, D. V. Vinogradov, A. S. Makarova, A. V. Demin, A. G. Paleeva, O. S. Kremenetskaya, A. A. Penin, A. V. Klepikova, A. S. Kasianov, D. A. Shavochkina, N. E. Kudashkin, Yu. I. Patyutko, N.
Biopolymers and Cell.2015; 31(6): 436.     CrossRef